13D/13G Filings - C4 Therapeutics Inc. (CCCC)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-02-16
3:48 pm
Purchase
2020-12-31 13G C4 Therapeutics, Inc.
CCCC
Perceptive Advisors LLC 3,158,566
7.300%
3,158,566increase
(New Position)
Filing
History
2021-02-16
3:03 pm
Sale
2020-12-31 13G C4 Therapeutics, Inc.
CCCC
Cormorant Asset Management LP 2,490,065
5.790%
-3decrease
(-0.00%)
Filing
History
2020-10-16
4:09 pm
Purchase
2020-10-06 13D C4 Therapeutics, Inc.
CCCC
COBRO VENTURES OPPORTUNITY FUND L.P. 4,341,930
10.100%
4,341,930increase
(New Position)
Filing
History
2020-10-16
4:00 pm
Purchase
2020-10-06 13G C4 Therapeutics, Inc.
CCCC
Cormorant Asset Management LP 2,490,068
5.790%
2,490,068increase
(New Position)
Filing
History
Goto Prev, 0, 1, 2